Gerson Lehrman Group, Inc. conducted a survey of nearly 50 physicians across Asia-Pacific to find out their drug prescribing preferences and hospital/formulary influences when considering foreign original branded therapies compared with local generic therapies. Respondents represented opinions from three distinct reimbursement markets: reimbursed, semi-reimbursed and self-pay markets.
Provided by: G+, part of Gerson Lehrman Group, Inc.
Download Whitepaper
All PharmaVOICE White Papers
